A Study to Evaluate the Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of Oral Doses of H008
Condition: Erosive Esophagitis Interventions: Drug: H008; Drug: H008 placebo; Drug: Lansoprazole Sponsor: Jiangsu Carephar Pharmaceutical Co., Ltd. Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 20, 2021 Category: Research Source Type: clinical trials
Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal Ulcer
Condition: Duodenal Ulcer Interventions: Drug: LXI-15028 50mg group; Drug: Lansoprazole 30mg group Sponsor: Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2021 Category: Research Source Type: clinical trials